{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:53:20Z","timestamp":1793922800342,"version":"4.8.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1743,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1365-2133.2010.10030.x","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T17:41:59Z","timestamp":1283881319000},"page":"415-428","source":"Crossref","is-referenced-by-count":220,"title":["Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1093","volume":"164","author":[{"given":"J.","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"von Kobyletzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Apfelbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","article-title":"Atopic dermatitis","volume":"361","author":"Leung","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N Engl J Med"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2010.10030.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.jaci.2003.09.033","article-title":"Atopic dermatitis and the atopic march","volume":"112","author":"Spergel","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jama.2009.136","article-title":"Atopic eczema and attention-deficit\/hyperactivity disorder in a population-based sample of children and adolescents","volume":"301","author":"Schmitt","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2133.2009.09309.x","article-title":"Psychiatric comorbidity in adult eczema","volume":"161","author":"Schmitt","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaci.2009.10.055","article-title":"Infant-onset eczema in relation to mental health problems at age 10\u2003years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus)","volume":"125","author":"Schmitt","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1525-1470.2005.22303.x","article-title":"The burden of atopic dermatitis: impact on the patient, family, and society","volume":"22","author":"Carroll","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMcp042803","article-title":"Clinical practice. Atopic dermatitis","volume":"352","author":"Williams","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jdermsci.2006.06.003","article-title":"Skin barrier function, epidermal proliferation and differentiation in eczema","volume":"43","author":"Proksch","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1523-1747.ep12514346","article-title":"The structure of normal skin and the morphology of atopic eczema","volume":"67","author":"Mihm","year":"1976","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1046\/j.1365-2133.1999.02893.x","article-title":"The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group","volume":"140","author":"van der Meer","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1398-9995.2008.01683.x","article-title":"Proactive treatment of atopic dermatitis in adults with 0\u00b71% tacrolimus ointment","volume":"63","author":"Wollenberg","year":"2008","journal-title":"Allergy"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.jaci.2007.08.011","article-title":"What are the best outcome measurements for atopic eczema? A systematic review","volume":"120","author":"Schmitt","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB14|cit14","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0","author":"Higgins","year":"2008"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Stat Med"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"e1210","DOI":"10.1542\/peds.2008-1343","article-title":"Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use","volume":"122","author":"Paller","year":"2008","journal-title":"Pediatrics"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jaad.2008.02.008","article-title":"Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle","volume":"58","author":"Breneman","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2133.2002.05006.x","article-title":"Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients","volume":"147","author":"Hanifin","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1365-2133.2008.08813.x","article-title":"Proactive disease management with 0\u00b703% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study","volume":"159","author":"Tha\u00e7i","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1399-3038.2008.00735.x","article-title":"Efficacy and safety of fluticasone propionate 0\u00b7005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls?","volume":"20","author":"Glazenburg","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2133.2008.08436.x","article-title":"Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study","volume":"158","author":"Peserico","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/bmj.326.7403.1367","article-title":"Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study","volume":"326","author":"Berth-Jones","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1365-2133.2008.08807.x","article-title":"Economic evaluation of maintenance treatment with tacrolimus 0\u00b71% ointment in adults with moderate to severe atopic dermatitis","volume":"159","author":"Wollenberg","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bmj.327.7421.942","article-title":"Topical corticosteroids in atopic dermatitis","volume":"327","author":"Atherton","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archderm.140.9.1151","article-title":"Twice-weekly topical corticosteroid therapy may reduce atopic dermatitis relapses","volume":"140","author":"Williams","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB26|cit26","volume-title":"Systematic Reviews in Health Care. Meta-analysis in Context","year":"2003"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000248314","article-title":"Steroid-induced dermal atrophy. Investigations on discontinuous application","volume":"179","author":"Lubach","year":"1989","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archderm.142.9.1190","article-title":"What is meant by a \u2018flare\u2019 in atopic dermatitis? A systematic review and proposal","volume":"142","author":"Langan","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1523-1747.2003.12251.x","article-title":"Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?","volume":"120","author":"Charman","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB30|cit30","article-title":"Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process","author":"Schmitt","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/bmj.324.7340.768","article-title":"Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema","volume":"324","author":"Thomas","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/000155599750010256","article-title":"Scoring the severity of atopic dermatitis: Three Item Severity Score as a rough system for daily practice and as a pre-screening tool for studies","volume":"79","author":"Wolkerstorfer","year":"1999","journal-title":"Acta Derm Venereol (Stockh)"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2010.10030.x-BIB33|cit33","first-page":"13","article-title":"Grading of the severity of atopic dermatitis","volume":"144","author":"Rajka","year":"1989","journal-title":"Acta Derm Venereol (Stockh)"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2010.10030.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2133.1994.tb08530.x","article-title":"The U.K. Working Party\u2019s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis","volume":"131","author":"Williams","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000245677","article-title":"Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis","volume":"195","author":"Kunz","year":"1997","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2010.10030.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1983.03330370053031","article-title":"If nothing goes wrong, is everything all right? Interpreting zero numerators","volume":"249","author":"Hanley","year":"1983","journal-title":"JAMA"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.10030.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.10030.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T02:24:18Z","timestamp":1685759058000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/164\/2\/415\/6643974"}},"subtitle":["Proactive treatment of eczema: a meta-analysis"],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10030.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717963743.793465619","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,23]]}}}